According to ICMR IndiaB study, only 31% of Indians with type 2 diabetes (T2DM) have HbA1c ≤ 7 %. Hence, we strategize FIT (Fortnight intensive treatment) care to achieve an early Glycemic control that could effectively sustain over an extended period. In this study, individuals (N=107) with T2DM, aged >18 years with HbA1c >7% were subjected to a combination therapy of single or multiple OADs with or without insulin and short-term (14-days) insulinization. FBS (Fasting Blood sugar) and PPBS levels (Post prandial blood sugar) were measured on Day 0, 5, 14 and 90. Based on Day 0 estimates, individualized FIT care was initiated to achieve a target of FBS (100 – 130 mg/dL) and PPBS (180 – 190 mg/dL) . Treatment was intensified and optimized on Day 5 and 14, respectively. HbA1c between Day 0 and Day 90 was compared.On Day 0, mean FBS, PPBS and HbA1c values were 223.6 ± 69.2 mg/dL, 338± 68.5 and 10.1 ±1.9 %, respectively. Individuals using multiple (≥3) OADs and insulin therapy were 25% at enrolment and 75% during FIT care. After FIT care, there has been a significant reduction in FBS and PPBS (Figure 1) . By day 90, there is a significant (P<0.0001) reduction of 3.13 % in the mean HbA1c levels compared to the levels during enrolment. About 64.5% had a sustained HbA1c% of ≤7. Figure 1: Effect of FIT care across visits In T2DM, FIT care’s glycemic control as early as day 5 and day 14 is beneficial for sustained glycemic control and reduction of treatment failure.


S.Ramanarayanan: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at